Shanghai Heben-Eastsun to Expand Azoxystrobin Technical Production in 2012
Shanghai Heben-Eastsun Medicaments Co., Ltd. (Shanghai Heben-Eastsun), one of the leading azoxystrobin producers in China, plans to expand its capacity of azoxystrobin technical to 500t/a from 300t/a this year, which will greatly enhance the company's competitiveness and bring it handsome profit in the near future, according to CCM’s March Issue of Fungicides China News.
View full press release